[PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology]
- PMID: 24199714
- DOI: 10.1016/S0151-9638(13)70138-8
[PDT panoramic view. Principle, photosensitizers, light sources and validated indications in dermatology]
Abstract
Introduction: Photodynamic therapy (PDT) combines the use of a topical sensitizer and its excitation with a light of appropriate wavelength. Its use in dermatooncology has been possible in France in 2006 when the methyl ester ALA or Metvixia® got approved.
Objective: To provide a panoramic view of validated indications of PDT in oncodermatology.
Method: This work is based on the review of the literature as well as available guidelines or recommendation on PDT in dermatology.
Results: Standardized protocols and results of the main clinical trials are given for the three major indications in dermatology: actinic keratosis, basal cell carcinoma and Bowen disease.
Conclusion: PDT has its role to play in the treatment of multiple superficial carcinomas and cutaneous precancerous lesions and its main advantage resides in its optimal healing.
Keywords: Actinic keratosis; Basal cell carcinoma; Bowen's disease; Carcinome basocellulaire superficiel; Kératoses actiniques; Maladie de Bowen; Photodynamic therapy.; Photothérapie dynamique.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.
Similar articles
-
The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.Eur J Dermatol. 2013 Jan-Feb;23(1):68-76. doi: 10.1684/ejd.2012.1896. Eur J Dermatol. 2013. PMID: 23400280
-
Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group.Br J Dermatol. 2002 Apr;146(4):552-67. doi: 10.1046/j.1365-2133.2002.04719.x. Br J Dermatol. 2002. PMID: 11966684 Review.
-
Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers.Skin Therapy Lett. 2009 Jul-Aug;14(6):1-3. Skin Therapy Lett. 2009. PMID: 19609473 Review.
-
European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications - actinic keratoses, Bowen's disease, basal cell carcinoma.J Eur Acad Dermatol Venereol. 2013 May;27(5):536-44. doi: 10.1111/jdv.12031. Epub 2012 Nov 26. J Eur Acad Dermatol Venereol. 2013. PMID: 23181594 Review.
-
European Dermatology Forum guidelines on topical photodynamic therapy 2019 Part 1: treatment delivery and established indications - actinic keratoses, Bowen's disease and basal cell carcinomas.J Eur Acad Dermatol Venereol. 2019 Dec;33(12):2225-2238. doi: 10.1111/jdv.16017. J Eur Acad Dermatol Venereol. 2019. PMID: 31779042
Cited by
-
Development of a novel formulation with hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro and in vivo studies.Antimicrob Agents Chemother. 2015 Sep;59(9):5804-13. doi: 10.1128/AAC.00545-15. Epub 2015 Jul 13. Antimicrob Agents Chemother. 2015. PMID: 26169411 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical